Exagen Announces Acceptance of Multiple Abstracts at ACR 2022 Annual Meeting

September 20, 2022

https://www.globenewswire.com/news-release/2022/09/20/2519697/32920/en/Exagen-Announces-Acceptance-of-Multiple-Abstracts-at-ACR-2022-Annual-Meeting.html

SAN DIEGO, Sept. 20, 2022 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq:XGN), a leading provider of autoimmune testing solutions, announced today the acceptance of nine abstracts at the 2022 American College of Rheumatology’s (ACR) annual meeting, ACR Convergence 2022, being held November 10-14, 2022, at the Pennsylvania Convention Center in Philadelphia, Pennsylvania.

Read more at globenewswire.com

Related news for (XGN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.